Purpose Chemotherapy-induced peripheral neuropathy (CIPN) may persist after treatment ends and may lead to functional decline and falls. This study compared objective and self-report measures of physical function, gait patterns, and falls between women cancer survivors with and without symptoms of CIPN to identify targets for functional rehabilitation. Methods A secondary data analysis of 512 women cancer survivors (age, 62 6 6 years; time since diagnosis, 5.8 6 4.1 years) categorized and compared women self-reporting symptoms of CIPN (CIPN+) with asymptomatic women (CIPN2) on the following: maximal leg strength, timed chair stand, physical function battery, gait characteristics (speed; step number, rate, and length; base of support), selfr...
Background We explored the impact of persistent sensory and motor taxane-induced peripheral neuropat...
Objective: Chemotherapy-induced peripheral neuropathy (CIPN) presents itself as sensory peripheral n...
Background: Cancer patients undergoing chemotherapy often experience chemotherapy-induced-peripheral...
Purpose Chemotherapy-induced peripheral neuropathy (CIPN) may persist after treatment ends and may ...
Objective: We investigated the incidence of falls and functional impairments in breast cancer patien...
Purpose: Chemotherapy-induced peripheral neuropathy (CIPN) affects up to 40% of cancer survivors and...
Limited information exists on the effects of self-reported exercise on subjective and objective meas...
Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a significant and often lasting sid...
Abstract Purpose Togaininsightintotheassociationofphysicalactivity (PA), chemotherapy-induced periph...
Chemotherapy induced peripheral neuropathy (CIPN) is a crippling side effect of some types of chemot...
Objective:An essential component for optimizing quality of life in adults with cancer is determining...
Twelve percent of women suffer from breast cancer each year, but survivorship is increasing due to i...
Objective. Chemotherapy-induced peripheral neuropathy (CIPN) presents itself as sensory peripheral n...
Objective This study assessed the prevalence and risk factors of chemotherapy-induced peripheral neu...
Background We explored the impact of persistent sensory and motor taxane-induced peripheral neuropat...
Objective: Chemotherapy-induced peripheral neuropathy (CIPN) presents itself as sensory peripheral n...
Background: Cancer patients undergoing chemotherapy often experience chemotherapy-induced-peripheral...
Purpose Chemotherapy-induced peripheral neuropathy (CIPN) may persist after treatment ends and may ...
Objective: We investigated the incidence of falls and functional impairments in breast cancer patien...
Purpose: Chemotherapy-induced peripheral neuropathy (CIPN) affects up to 40% of cancer survivors and...
Limited information exists on the effects of self-reported exercise on subjective and objective meas...
Background: Chemotherapy-induced peripheral neuropathy (CIPN) is a significant and often lasting sid...
Abstract Purpose Togaininsightintotheassociationofphysicalactivity (PA), chemotherapy-induced periph...
Chemotherapy induced peripheral neuropathy (CIPN) is a crippling side effect of some types of chemot...
Objective:An essential component for optimizing quality of life in adults with cancer is determining...
Twelve percent of women suffer from breast cancer each year, but survivorship is increasing due to i...
Objective. Chemotherapy-induced peripheral neuropathy (CIPN) presents itself as sensory peripheral n...
Objective This study assessed the prevalence and risk factors of chemotherapy-induced peripheral neu...
Background We explored the impact of persistent sensory and motor taxane-induced peripheral neuropat...
Objective: Chemotherapy-induced peripheral neuropathy (CIPN) presents itself as sensory peripheral n...
Background: Cancer patients undergoing chemotherapy often experience chemotherapy-induced-peripheral...